Yantacaw Capital
Venture fund · from SEC filings

Oncology Ventures Fund I-A LP

Oncology Ventures · adviser of record: Oncology Ventures LLC · 2024 vintage

Oncology Ventures Fund I-A LP is a 2024 venture fund managed by Oncology Ventures, with $5mm raised (Form D, amount sold). It reported $7mm in gross assets at year-end 2025, 1.40x its size, its highest reported value.

Latest value held
$7mm year-end 2025
Peak
$7mm year-end 2025
Fund size
$5mm Form D, amount sold
Held vs. size
1.40x peak 1.40x

Value held by year-end

$2mm$4mm$6mm$8mm2025

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2025$7mm1.40x–

Other funds from Oncology Ventures

All Oncology Ventures funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-1607311474. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.